Bio-Techne (MEX:TECH) Beneish M-Score: -2.55 (As of Jun. 26, 2026)

What is Bio-Techne Beneish M-Score?

Bio-Techne MEX:TECH 83 Beneish M-Score is -2.55 as of Jun. 26, 2026. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,117.60. The stock has 8 warning signs investors should review. Among 831 Biotechnology companies, Bio-Techne ranks better than 58.12% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.55 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Bio-Techne's Beneish M-Score or its related term are showing as below:

MEX:TECH' s Beneish M-Score Range Over the Past 10 Years
Min: -2.86 Med: -2.54 Max: -2.33
Current: -2.55

During the past 13 years, the highest Beneish M-Score of Bio-Techne was -2.33. The lowest was -2.86. And the median was -2.54.

Bio-Techne Beneish M-Score Related Terms

Bio-Techne Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Beneish M-Score Chart

Bio-Techne Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Beneish M-Score

Get a 7-Day Free Trial

-2.54

-2.33

-2.40

-2.52

-2.78

Bio-Techne Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Beneish M-Score	Get a 7-Day Free Trial															-2.60	-2.78	-2.73	-2.65	-2.55

MEX:TECH vs HALO, IBRX, NUVL: Beneish M-Score Comparison

For the Biotechnology subindustry, Bio-Techne's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Techne Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Beneish M-Score falls into.

Save Embed

83GF Score

Bio-Techne Corp MEX:TECH

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bio-Techne Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Bio-Techne for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.8624

0.528 * 1.0127

0.404 * 0.9627

0.892 * 0.9248

0.115 * 0.9588

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.7843

4.679 * -0.016938

0.327 * 0.7694

-2.65

This Year (Mar26) TTM:

Last Year (Mar25) TTM:

Total Receivables was MXN3,869 Mil.
Revenue was 5615.653 + 5327.473 + 5256.622 + 5968.179 = MXN22,168 Mil.
Gross Profit was 3755.995 + 3444.076 + 3450.764 + 3743.471 = MXN14,394 Mil.
Total Current Assets was MXN12,407 Mil.
Total Assets was MXN45,994 Mil.
Property, Plant and Equipment(Net PPE) was MXN5,433 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN1,838 Mil.
Selling, General, & Admin. Expense(SGA) was MXN6,588 Mil.
Total Current Liabilities was MXN2,764 Mil.
Long-Term Debt & Capital Lease Obligation was MXN4,980 Mil.
Net Income was 920.515 + 684.379 + 700.473 + -332.863 = MXN1,973 Mil.
Non Operating Income was -51.375 + -43.268 + 42.118 + -2597.582 = MXN-2,650 Mil.
Cash Flow from Operations was 1562.732 + 1483.868 + 506.025 + 1849.046 = MXN5,402 Mil.

Total Receivables was MXN4,851 Mil.
Revenue was 6468.494 + 6194.789 + 5699.515 + 5607.765 = MXN23,971 Mil.
Gross Profit was 4389.43 + 4043.628 + 3603.66 + 3725.356 = MXN15,762 Mil.
Total Current Assets was MXN12,832 Mil.
Total Assets was MXN54,097 Mil.
Property, Plant and Equipment(Net PPE) was MXN6,869 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN2,197 Mil.
Selling, General, & Admin. Expense(SGA) was MXN9,082 Mil.
Total Current Liabilities was MXN3,462 Mil.
Long-Term Debt & Capital Lease Obligation was MXN8,377 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(3869.132 / 22167.927)	/	(4851.458 / 23970.563)
	=	0.174537	/	0.202392
	=	0.8624

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(15762.074 / 23970.563)	/	(14394.306 / 22167.927)
	=	0.65756	/	0.64933
	=	1.0127

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (12407.399 + 5433.361) / 45994.223)	/	(1 - (12832.201 + 6869.168) / 54096.78)
	=	0.612109	/	0.635813
	=	0.9627

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	22167.927	/	23970.563
	=	0.9248

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(2196.942 / (2196.942 + 6869.168))	/	(1837.711 / (1837.711 + 5433.361))
	=	0.242325	/	0.252743
	=	0.9588

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(6587.719 / 22167.927)	/	(9081.971 / 23970.563)
	=	0.297173	/	0.37888
	=	0.7843

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((4979.568 + 2764.016) / 45994.223)	/	((8376.61 + 3461.609) / 54096.78)
	=	0.16836	/	0.218834
	=	0.7694

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(1972.504 - -2650.107	-	5401.671)	/	45994.223
	=	-0.016938

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Bio-Techne has a M-score of -2.65 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of -2.55 mean?

Bio-Techne (MEX:TECH) has a Beneish M-Score of -2.55 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bio-Techne and its competitors. According to the industry distribution chart, Bio-Techne ranks #348 out of 831 companies in the Biotechnology industry, placing it in the top 41.9%.

Is Bio-Techne's Beneish M-Score too high?

Bio-Techne's current Beneish M-Score is -2.55. Based on the distribution chart, Bio-Techne ranks #348 out of 831 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.

How does Bio-Techne's Beneish M-Score compare to HALO and IBRX?

According to the Biotechnology industry distribution chart, Bio-Techne ranks #348 out of 831 companies for Beneish M-Score. This puts Bio-Techne in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Biotechnology company?

A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bio-Techne and its competitors. Bio-Techne's current Beneish M-Score is -2.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bio-Techne stock overvalued right now?

Bio-Techne (MEX:TECH) has a current Beneish M-Score of -2.55. The stock's GF Value™ is MXN1,117.60, compared to a current price of MXN1,090.00 — trading 2.5% below its estimated fair value. The current Beneish M-Score is -2.55. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Beneish M-Score is -2.55 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MEX:TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of MXN1,090.00 is trading 2.5% below its estimated GF Value™ of MXN1,117.60.

Key valuation signals for MEX:TECH:

Beneish M-Score: -2.55
GF Value™: MXN1,117.60 vs. price of MXN1,090.00 (2.5% below fair value)
GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Techne Business Description

Industry Healthcare Biotechnology

Comparable Companies HALO IBRX NUVL CORT PCVX KRYS IMVT KYMR CELC PRAX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges TECH:USA TE1:Germany T1CH34:Brazil

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

83GF Score

Get the complete analysis for MEX:TECH

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,090.00

Price

MXN1,117.60

GF Value

View MEX:TECH Analysis

See Beneish M-Score data for all stocks →